Skip to main navigation
logo
  • About
    • Company
    • Leadership
    • Laboratory
    • Careers
  • Products
    • IMMUNO-/PRECISION ONCOLOGY
      • Immuno ID NeXT PlatformTM
      • NeXT PersonalTM
      • NeXT Liquid BiopsyTM
    • ONCOLOGY CLINICAL DIAGNOSTICS
      • NeXT Dx TestTM
    • PHARMA RESEARCH SOLUTIONS
      • Exome Sequencing
      • Transcriptome Sequencing
      • Whole Genome Sequencing
      • Targeted Cancer Panels
      • miRNA Sequencing
  • Applications
    • Biomarker Discovery
    • Personalized Therapeutics
    • Population Genomics
  • Technology
    • Our Processes
    • Unlock the power of DNA
    • Optimizing RNA
    • NeoantigenID
    • MHC binding prediction
    • ImmunogenomicsID
    • Reliable delivery
  • Resources
    • What’s New
    • Conferences
    • Library
    • Blog
    • Contact
  • Investors
    • Overview
    • Press Releases
    • Events
    • SEC Filings
    • Stock Information
    • Corporate Governance
    • Analyst Coverage
    • Investor FAQs
    • Investor Contacts
    • Email Alerts

Press Releases

Press Releases

May 04, 2022
Personalis Reports First Quarter 2022 Financial Results
Apr 28, 2022
Personalis to Present at Upcoming Investor Conferences
Apr 26, 2022
Evaxion to Utilize Personalis’ ImmunoID NeXT Platform® to Evaluate Efficacy of Combination Therapy for Late-Stage Melanoma
Apr 21, 2022
Personalis Expands Diagnostic Leadership Team With Appointment of James Azzaro, Vice President of Diagnostic Sales
Apr 20, 2022
Personalis to Announce First Quarter 2022 Financial Results
Apr 12, 2022
Personalis Publishes New Data Demonstrating Highly Sensitive Algorithm for Detecting Loss of Heterozygosity in HLA Gene
Apr 12, 2022
Personalis Announces Issuance of Additional US Patent Related to the NeXT Personal™ Platform
Apr 11, 2022
Personalis and Merck KGaA, Darmstadt, Germany to Present Comprehensive Tumor Subtyping Collaboration Data at AACR Annual Meeting 2022
Mar 31, 2022
Personalis to Present at the 21st Annual Needham Virtual Healthcare Conference
Mar 24, 2022
Diagnostic Industry Veteran Karin Eastham to Chair Personalis Board of Directors

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 17
Print Page
RSS Feeds
Email Alerts
Contact IR
Corporate Website
© 2022 Personalis Inc. All rights reserved.
logo